Microbial Biofilms : Role in Human Infectious Diseases / Mukesh Kumar Yadav, Jae Jun Song, and Jorge E. Vidal, editors.

Format:

Book

Contributor:

Yadav, Mukesh Kumar, editor.

Song, Jae Jun, editor.

Vidal, Jorge E., editor.

Series:

Developments in microbiology.

Developments in Microbiology Series

Language:

English

Subjects (All):

Biofilms.

Physical Description:

1 online resource (291 pages)

Edition:

First edition.

Place of Publication:

Cambridge, MA : Stacy Masucci, [2024]

Summary:

Microbial biofilms: Role in Human Infectious Diseases focuses on new and emerging concepts in microbial biofilm research, such as the mechanisms of biofilm formation, biofilm-induced pathogenesis, biofilm detection/and diagnosis, gene exchange within biofilms, strategies to control microbial biofilms and the burden of biofilm associated infections.

Contents:

Front Cover

Microbial Biofilms

Copyright Page

Contents

List of contributors

1 Application of nanoparticles to combat dental biofilms

1.1 Dental biofilms

1.1.1 Background

1.1.1.1 Acquired pellicle formation

1.1.1.2 Initial attachment to a surface

1.1.1.3 Biofilm maturation

1.1.1.4 Dispersal of bacteria

1.1.2 Current treatment methods

1.1.2.1 Physical or mechanical removal

1.1.2.2 Chemical removal

1.1.3 Newer antibacterial treatment methods

1.2 Nanoparticles

1.2.1 Background

1.2.2 Applications in medicine

1.2.3 Organic nanoparticles

1.2.3.1 Liposomes and lipid nanoparticles

1.2.3.2 Polymeric nanoparticles

1.2.3.3 Dendritic nanoparticles

1.2.4 Inorganic nanoparticles

1.2.4.1 Gold nanoparticles

1.2.4.2 Silver nanoparticles

1.2.4.3 Iron oxide nanoparticles

1.2.5 Hybrid nanoparticles

1.3 Application of nanoparticles to treat dental biofilms

1.3.1 Surface coatings of dental materials

1.3.2 Incorporation into dental materials

1.3.3 Drug delivery

1.3.4 Wound healing

1.3.5 Infection detection

1.4 Treatment of periodontal disease

1.4.1 Periodontal disease

1.4.2 Challenges faced in treating periodontal disease

1.4.3 Use of nanoparticles to treat periodontitis

1.5 Future perspective on the applications of nanoparticles

1.6 Conclusion

References

2 Streptococcus biofilms: role in human infectious diseases

2.1 Introduction

2.2 Classification of Streptococcus species

2.2.1 Group A Streptococcus

2.2.2 Group B Streptococcus

2.2.3 Group C Streptococcus

2.2.4 Group D Streptococcus

2.2.5 Group F Streptococcus

2.2.6 Group G Streptococcus

2.3 Biofilm mode of growth of Streptococcus species

2.3.1 Streptococcus pneumoniae

2.3.2 Streptococcus pyogenes

2.3.3 Streptococcus mutans

2.3.4 Streptococcus gordonii.

2.3.5 Streptococcus sanguinis

2.4 Streptococcus biofilm-related infectious diseases

2.4.1 Pneumonia

2.4.2 Otitis media

2.4.3 Periodontitis

2.4.4 Endocarditis

2.5 Conclusion and future perspective

Acknowledgment

3 Single-species and multispecies biofilms causing infections

3.1 Introduction

3.2 Role of biofilm in disease

3.2.1 Immune avoidance

3.2.2 Device-related and nondevice-related biofilm infections

3.2.3 Device related

3.2.3.1 Catheter-related bloodstream infections

3.2.3.2 Prosthetic joint infection

3.2.4 Nondevice related

3.2.4.1 Respiratory infections

3.2.4.2 Gastrointestinal tract

3.3 Concluding remarks

4 Gut microbiota: role of biofilms in human health

4.1 Introduction

4.2 Types of bacteria and their spatial distribution

4.3 The trajectory of gut microbiota in infants

4.3.1 Gestational period

4.3.2 The mode of delivery

4.3.3 Feeding habits

4.4 Factors affecting gut microbiota

4.4.1 Antibiotics

4.4.2 Body mass index

4.4.3 Dietary habits

4.4.4 Exercise

4.4.5 Age

4.5 Microbial dysbiosis

4.5.1 Irritable bowel syndrome

4.5.2 Inflammatory bowel diseases

4.5.3 Celiac disease

4.5.4 Colorectal cancer

4.5.5 Type 2 diabetes

4.5.6 Neurological disorders

4.5.6.1 Alzheimer's disease

4.5.6.2 Parkinson's disease

4.5.6.3 Hepatic encephalopathy-related cognitive impairment

4.6 Gut metabolite

4.6.1 Short-chain fatty acids

4.6.2 Trimethylamine N-oxide

4.6.3 Urolithin

4.6.4 Indole propionic acid

4.7 Microbial biofilm

4.7.1 Composition of biofilm

4.7.1.1 Polysaccharide intercellular adhesion

4.7.1.2 Pseudomonas aeruginosa Pel

4.7.1.3 Pseudomonas aeruginosa Psl

4.7.1.4 Alginate

4.7.2 Biofilm and infectious disease

4.7.2.1 Infective endocarditis

4.7.2.2 Cystic fibrosis.

4.7.2.3 Otitis media

4.8 Conclusion

5 Natural compounds to combat microbial biofilms

5.1 Introduction

5.2 Terpenes

5.2.1 Monoterpenes

5.2.1.1 Carvacrol

5.2.1.2 Thymol

5.2.2 Sesquiterepenes

5.2.2.1 Farnesol

5.2.3 Diterpenes

5.2.3.1 Phytol

5.2.4 Triterpenes

5.2.5 Tetraterpenes

5.3 Flavonoids

5.3.1 Flavones

5.3.2 Chalcones

5.3.3 Anthocyanins

5.3.4 Isoflavones

5.3.5 Flavonols

5.4 Alkaloids

5.4.1 Alkaloids and antibiofilm activity

5.4.1.1 Indole alkaloids

5.4.1.2 Quinolizidine-type alkaloids

5.4.1.3 Imidazole-type alkaloids

5.5 Conclusions

6 Vaginal microbiota biofilm in pregnancy and birth outcome: function and prospects

6.1 Introduction

6.2 Vaginal microbiota profile and dysbiosis during pregnancy

6.3 Vaginal microbiota dysbiosis and biofilm formation during pregnancy

6.4 Vaginal microbiota biofilm formation during pregnancy and birth outcome

6.5 Therapeutic insight of beneficial against pathogenic vaginal microbiota biofilm

6.6 Conclusion and future prospective

Author contributions

Acknowledgments

Conflict of interest

7 Microbial biofilms and their role in acute and chronic pathogenesis

7.1 Introduction to biofilm: a microbial life on surface

7.2 Historical perspective of biofilm

7.3 Biofilm and its structural component

7.4 Biofilm mode of growth of bacteria

7.4.1 Initial attachment to a surface

7.4.2 Microcolony formation

7.4.3 Three-dimensional structure formation and maturation

7.4.4 Detachment and dispersal

7.5 Role of biofilms in human health

7.5.1 Endocarditis

7.5.2 Atherosclerosis

7.5.3 Inflammatory bowel disease and colorectal cancer

7.5.4 Bacterial vaginosis

7.6 Microbiome and biofilm formation in lungs.

7.7 Role of biofilms in respiratory tract and acute and chronic pathogenesis

7.7.1 Chronic rhinosinusitis

7.7.2 Cystic fibrosis

7.7.3 Pertussis and other Bordertella infections

7.7.4 Tuberculosis

7.8 Control of biofilms in respiratory infection

7.9 Conclusion

8 Surface modification: strategies to prevent microbial growth on medical implants

8.1 Introduction

8.2 Understanding microbial growth on medical implants

8.2.1 Microbial biofilm

8.3 Inhibition of microbial adhesion to device surfaces

8.3.1 Hydrophilic coatings

8.3.2 Antimicrobial-coated urinary catheters

8.3.3 Antimicrobial-coated orthopedic implants

8.3.4 Antimicrobial-coated central venous catheter

8.4 Promoting microbial killing within an established biofilm

8.5 Physical surface modification

8.6 Nanopatterning

8.7 Surface chemical modifications

8.8 Conclusion and future prospective

9 Microbial biofilms and the skin microbiome

9.1 Introduction

9.2 Microbial biofilm and skin disease

9.2.1 Chronic wound infection

9.2.2 Acne

9.2.3 Atopic eczema

9.2.4 Candidiasis

9.2.5 Onychomycosis

9.3 Skin burn infection

9.4 Pressure ulcers

9.5 Conclusion

10 Cell-to-cell interaction and cell signaling in biofilm formation

10.1 Introduction

10.1.1 Resistance of biofilms to antibiotics

10.1.2 Properties of microbial biofilms

10.2 Relevance and risk of biofilm

10.2.1 Otitis media

10.2.2 Infective endocarditis

10.2.3 Atherosclerosis

10.2.4 Sialolithiasis

10.2.5 Recalcitrant typhoid fever and predisposition to hepatobiliary cancers

10.2.6 Inflammatory bowel disease

10.2.7 Wound infections

10.2.8 Bacterial vaginosis

10.2.9 Chronic endometritis

10.2.10 Mastitis

10.2.11 Chronic rhinosinusitis.

10.2.12 Pharyngitis and laryngitis

10.2.13 Pertussis and other Bordetella infections

10.2.14 Cystic fibrosis

10.2.15 Urinary tract infections

10.3 Factors associated with biofilm formations

10.3.1 Role of cyclic guanosine mono phosphate (cGMP)

10.3.2 Hydrodynamic conditions

10.3.3 Environmental conditions

10.3.4 pH

10.3.5 Temperature

10.3.6 Oxygen availability

10.3.7 Nutrition status

10.4 Mechanism of biofilm formation and cell-to-cell interaction

10.4.1 Early adhesion phase

10.4.2 Irreversible adhesion to the surface

10.4.3 Microcolony formation

10.4.4 Biofilm maturation

10.5 Relevance and risk of biofilm

10.6 Factors associated with biofilm formation

10.6.1 Media composition

10.6.2 pH and temperature

10.6.3 Aerobic conditions

10.6.4 Antimicrobial exposure

10.7 Cell-to-cell signaling and signal interception

10.7.1 Quorum sensing

10.7.2 Surface motility

10.7.2.1 Swarming

10.7.2.2 Twitching

10.7.2.2.1 Crawling

10.7.2.2.2 Walking

10.7.2.2.3 Slingshot motility

10.7.2.3 Gliding

10.7.2.4 Sliding

10.8 Conclusions and future prospective

11 A concise review on genes involved in biofilm-related disease and differential gene expression in medical-related biofilms

11.1 Introduction

11.2 Genes involved in biofilm formation

11.2.1 Quorum-sensing genes

11.2.2 Genes for surface adhesion

11.2.3 Genes for biofilm formation

11.2.4 Genes for biofilm detachment

11.3 Differential gene expression in pathogenic biofilms

11.3.1 Upregulated genes

11.3.1.1 Extracellular polymeric substances production

11.3.1.2 Stress response

11.3.1.3 Efflux pumps

11.3.1.4 Antibiotic resistance

11.3.1.5 Persister cells

11.3.2 Downregulated genes

11.3.2.1 Motility

11.3.2.2 DNA repair

11.3.2.3 Metabolic activity.

11.4 Genes involved in pathogenic biofilms.

Notes:

Includes bibliographical references and index.

Description based on publisher supplied metadata and other sources.

Description based on print version record.

ISBN:

9780443192531

0443192537

OCLC:

1432603363